Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bommer

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The European Respiratory Journal|June 1, 1995
Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of lifeM P Rutten-van Mölken, F Custers, E K van Doorslaer, et al.
Clinical and Experimental Immunology|October 27, 2016
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disordersC Wehling, O Amon, M Bommer, et al.
Bone Marrow Transplantation|March 8, 2016
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCTS Bohl, S von Harsdorf, M Mulaw, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The European Respiratory Journal|June 1, 1995
Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of lifeM P Rutten-van Mölken, F Custers, E K van Doorslaer, et al.
Clinical and Experimental Immunology|October 27, 2016
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disordersC Wehling, O Amon, M Bommer, et al.
Bone Marrow Transplantation|March 8, 2016
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCTS Bohl, S von Harsdorf, M Mulaw, et al.
Pageof 4